Creathor Venture, RVC and KfW invest in Sividon Diagnostics

The investment will allow the company to develop and market its in-vitro diagnostics products for personalised medicine.

Company
Sividon Diagnostics is a spin-off from the diagnostics division of Siemens Healthcare founded in 2011. Currently Sividon employs 12 people at its headquarters in Cologne.

The company is currently launching the first product from its pathology laboratories which will allow a more accurate assessment of breast cancer. Sividon is looking to develop further products in breast cancer and other oncological indications.

People
Wilfried Frohnhofen represents Rheinland Venture Capital.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• Germany